Monopar Therapeutics files to sell 882,761 shares of common stock for holders
Source: SeekingAlpha
2025-01-15 17:07:31 ET
More on Monopar Therapeutics
- Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways
- Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus
- Monopar Therapeutics announces pricing of $40M public offering of common stock
Read the full article on Seeking Alpha
For further details see:
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
Monopar Therapeutics Inc.
NASDAQ: MNPR
MNPR Trading
0.88% G/L:
$62.30 Last:
21,892 Volume:
$61.42 Open:
MNPR Latest News
March 02, 2026 08:00:00 am
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
November 13, 2025 08:00:00 am
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
MNPR Stock Data
$384,114,928
4,169,932
0.03%
12
N/A
Biotechnology & Life Sciences
Healthcare
US
Wilmette
